These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 22928522)

  • 1. Using Mendelian randomization to determine causative factors in cardiovascular disease.
    Johansen CT; Hegele RA
    J Intern Med; 2013 Jan; 273(1):44-7. PubMed ID: 22928522
    [No Abstract]   [Full Text] [Related]  

  • 2. [Causality can be shown with mendelian randomization. Cardiovascular risk relations tested with the method].
    Nilsson PM
    Lakartidningen; 2013 Apr 17-23; 110(16):832-5. PubMed ID: 23717930
    [No Abstract]   [Full Text] [Related]  

  • 3. Mendelian randomization: present and future of epidemiological studies in cardiology.
    Iturrieta-Zuazo I; Walter S
    Rev Esp Cardiol (Engl Ed); 2015 Feb; 68(2):87-91. PubMed ID: 25449812
    [No Abstract]   [Full Text] [Related]  

  • 4. Mendelian randomization: how genetics is pushing the boundaries of epidemiology to identify new causes of heart disease.
    Thanassoulis G
    Can J Cardiol; 2013 Jan; 29(1):30-6. PubMed ID: 23199790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic study confirms causal link between adiposity and cardiometabolic disease.
    BMJ; 2013 Jul; 347():f4199. PubMed ID: 23823996
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic variation in HDL-related genes and the association with cardiovascular disease: HDL particles as chameleons of lipoprotein metabolism.
    Kronenberg F
    J Intern Med; 2011 Aug; 270(2):128-31. PubMed ID: 21575086
    [No Abstract]   [Full Text] [Related]  

  • 7. Limits of Mendelian randomization analyses in selection of secretory phospholipase A2-IIA as a valid therapeutic target for prevention of cardiovascular disease.
    Rosenson RS; Hurt-Camejo E
    J Am Coll Cardiol; 2014 Mar; 63(9):942-3. PubMed ID: 24315918
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetically elevated bilirubin and risk of ischaemic heart disease: three Mendelian randomization studies and a meta-analysis.
    Stender S; Frikke-Schmidt R; Nordestgaard BG; Grande P; Tybjaerg-Hansen A
    J Intern Med; 2013 Jan; 273(1):59-68. PubMed ID: 22805420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mendelian Randomization Analyses for Selection of Therapeutic Targets for Cardiovascular Disease Prevention: a Note of Circumspection.
    Rosenson RS; Koenig W
    Cardiovasc Drugs Ther; 2016 Feb; 30(1):65-74. PubMed ID: 26797681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insight into rheumatological cause and effect through the use of Mendelian randomization.
    Robinson PC; Choi HK; Do R; Merriman TR
    Nat Rev Rheumatol; 2016 Aug; 12(8):486-96. PubMed ID: 27411906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commentary on: "The contribution of tissue-specific BMI-associated gene sets to cardiometabolic disease risk: a Mendelian randomization study".
    Kutalik Z
    Int J Epidemiol; 2020 Aug; 49(4):1257-1258. PubMed ID: 32386404
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply: limits of Mendelian randomization analyses in selection of secretory phospholipase A2-IIA as a valid therapeutic target for prevention of cardiovascular disease.
    Holmes MV; Simon T; Exeter HJ; Hingorani AD; Sabatine MS; Mallat Z; Casas JP; Talmud PJ
    J Am Coll Cardiol; 2014 Mar; 63(9):943. PubMed ID: 24315920
    [No Abstract]   [Full Text] [Related]  

  • 13. Mendelian randomization: application to cardiovascular disease.
    Timpson NJ; Wade KH; Smith GD
    Curr Hypertens Rep; 2012 Feb; 14(1):29-37. PubMed ID: 22161218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mendelian Randomization.
    Birney E
    Cold Spring Harb Perspect Med; 2022 May; 12(4):. PubMed ID: 34872952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mendelian randomization suggests non-causal associations of testosterone with cardiometabolic risk factors and mortality.
    Haring R; Teumer A; Völker U; Dörr M; Nauck M; Biffar R; Völzke H; Baumeister SE; Wallaschofski H
    Andrology; 2013 Jan; 1(1):17-23. PubMed ID: 23258625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mendelian Randomization Supports a Causal Effect of Depression on Cardiovascular Disease as the Main Source of Their Comorbidity.
    de Geus EJC
    J Am Heart Assoc; 2021 Jan; 10(1):e019861. PubMed ID: 33372533
    [No Abstract]   [Full Text] [Related]  

  • 17. Vitamin C and primary prevention of cardiovascular disease: the case for Mendelian randomization.
    Santos RD
    Eur J Prev Cardiol; 2022 Jan; 28(16):1838-1839. PubMed ID: 34057997
    [No Abstract]   [Full Text] [Related]  

  • 18. Vitamin C and the risk of cardiovascular diseases: Mendelian randomization study may be misleading.
    Hemilä H; Chalker E
    Eur J Prev Cardiol; 2022 Jul; 29(9):e291-e292. PubMed ID: 35512139
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship Between Blood Pressure and Incident Cardiovascular Disease: Linear and Nonlinear Mendelian Randomization Analyses.
    Malik R; Georgakis MK; Vujkovic M; Damrauer SM; Elliott P; Karhunen V; Giontella A; Fava C; Hellwege JN; Shuey MM; Edwards TL; Rogne T; Åsvold BO; Brumpton BM; Burgess S; Dichgans M; Gill D
    Hypertension; 2021 Jun; 77(6):2004-2013. PubMed ID: 33813844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mendelian molecular genetics in glaucoma].
    Călugăru D
    Oftalmologia; 2010; 54(3):8-20. PubMed ID: 21137185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.